Overexpressed in aromatase inhibitor resistant estrogen receptor-positive (ER+) breast cancer; highly expressed at the cancer stem-like stage; upregulated with CUL4A-mediated increase in proliferation and tumorigenicity of breast cancer cells. This evidence concerns the gene CUL4A and breast cancer.